Home › Companies › ENANTA PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ENANTA PHARMACEUTICALS INC.’s Form 8-K, filed March 12, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of March 6, 2024: 6 items on ENANTA PHARMACEUTICALS INC.’s Form 8-K, filed March 12, 2024: 3 elected · 3 approved.
Significant dissent: 1 director (20.9% against); 1 equity or compensation plan (47.9% against).
Notable dissent: 2 directors (16.3%, 15.4% against); 1 say-on-pay vote (79.4% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore ENANTA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ENANTA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed March 12, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Yujiro S. Hata | 13,127,063 | -- | -- | 2,392,002 | 1,156,191 | 85% | Elected | — |
| Elect Director: Kristine Peterson | 12,994,324 | -- | -- | 2,524,741 | 1,156,191 | 84% | Elected | — |
| Elect Director: Terry C. Vance | 12,169,732 | -- | -- | 3,209,519 | 1,296,005 | 79% | Elected | — |
| 2. To Approve an Amendment to Our 2019 Equity Incentive Plan | 8,076,566 | 7,421,300 | 21,356 | -- | 1,156,034 | 52.1% | Approved | — |
| 3. To Approve, on an Advisory Basis, the Compensation Paid to the Company's Named Executive Officers | 12,306,697 | 3,196,342 | 16,183 | -- | 1,156,034 | 79% | Approved | — |
| 4. To Ratify the Appointment of PricewaterhouseCoopers LLP as Enanta's Independent Registered Public Accounting Firm for the 2024 Fiscal Year | 14,571,800 | 27,373 | 2,076,083 | -- | 0 | 99.8% | Approved | — |
Source: ENANTA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on March 12, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
143 asset managers disclosed a vote on at least one ENANTA PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Kristine Peterson
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Kristine Peterson”): 12,994,324 for, 2,524,741 withheld, per its Form 8-K filed March 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders re-elected the following individuals as Class II directors of the Company:”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 121,292 | Withhold |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 0 | 16,666 | Mixed |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,653 | 0 | 0 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 4,188,597 for, 145,534 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 120,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 120,000 for.
Combines 4 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Terry C. Vance
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Terry C. Vance”): 12,169,732 for, 3,209,519 withheld, per its Form 8-K filed March 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders re-elected the following individuals as Class II directors of the Company:”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 121,292 | Withhold |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 31,409 | 0 | 0 | 27,930 | Mixed |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 0 | 16,666 | Mixed |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,653 | 0 | 0 | 0 | For |
| State Street | 1,124 | 0 | 0 | 10,071 | Mixed |
Fund voting reports, all 58 managers: 4,122,921 for, 211,210 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 120,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 120,000 for.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors to serve until the 2027 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Yujiro S. Hata
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Yujiro S. Hata”): 13,127,063 for, 2,392,002 withheld, per its Form 8-K filed March 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The stockholders re-elected the following individuals as Class II directors of the Company:”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 121,292 | Withhold |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 0 | 16,666 | Mixed |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,653 | 0 | 0 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 4,188,597 for, 145,534 withheld. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 120,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 120,000 for.
Combines 3 wordings of this item as funds reported it.
52.1% Approved · of votes cast
Description as filed by funds: To approve an amendment to our 2019 Equity Incentive Plan.
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“2. To Approve an Amendment to Our 2019 Equity Incentive Plan”): 8,076,566 for, 7,421,300 against — passed, per its Form 8-K filed March 12, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the amendment to our 2019 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance under the plan by 975,000 shares.”
Support: 52.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,775,145 | 28,600 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 408,677 | 34,394 | 0 | 0 | Mixed |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 121,292 | 0 | 0 | 0 | For |
| Dimensional | 0 | 89,686 | 0 | 0 | Against |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 9,753 | 70,960 | 0 | 0 | Mixed |
| JPMorgan | 0 | 80,144 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 68,513 | 0 | 0 | Against |
| Equitable | 31,409 | 27,930 | 0 | 0 | Mixed |
| TIAA | 0 | 54,434 | 0 | 0 | Against |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 0 | 31,473 | 0 | 0 | Against |
| Lincoln Financial | 0 | 27,653 | 0 | 0 | Against |
| Bridge Builder Trust | 7,870 | 16,666 | 0 | 0 | Mixed |
| GuideStone | 0 | 22,417 | 0 | 0 | Against |
| Thrivent | 0 | 15,689 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 15,412 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 14,601 | 0 | 0 | Against |
| Northern Trust | 0 | 14,191 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 13,653 | 0 | 0 | Against |
| State Street | 0 | 11,195 | 0 | 0 | Against |
Fund voting reports, all 58 managers: 3,605,757 for, 724,911 against, 3,463 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 120,000 | 0 | 0 | Against |
Institutional-manager reports, all 1 managers: 120,000 against.
Combines 7 wordings of this item as funds reported it.
79% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation paid to our named executive officers, as disclosed in the proxy statement.
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“3. To Approve, on an Advisory Basis, the Compensation Paid to the Company's Named Executive Officers”): 12,306,697 for, 3,196,342 against — passed, per its Form 8-K filed March 12, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the advisory vote on executive compensation, referred to as a "say-on-pay" vote.”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 121,292 | 0 | 0 | Against |
| Dimensional | 0 | 89,686 | 0 | 0 | Against |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 52,200 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 23,975 | 3,678 | 0 | 0 | Mixed |
| Bridge Builder Trust | 24,536 | 0 | 0 | 0 | For |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 0 | 13,900 | 0 | 0 | Against |
| AIG/SunAmerica | 13,653 | 0 | 0 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 3,987,472 for, 343,196 against, 3,463 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 0 | 2,070,000 | 0 | 0 | Against |
| BlackRock | 809,093 | 0 | 0 | 0 | For |
| DE Shaw | 504,484 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 430,982 | 0 | 0 | 0 | For |
| Renaissance | 409,563 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 385,146 | 0 | 0 | 0 | For |
| Northern Trust | 383,250 | 38 | 0 | 0 | For |
| State Street | 374,947 | 157 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 289,233 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 223,764 | 0 | 0 | Against |
| UBS | 0 | 214,897 | 0 | 0 | Against |
| Two Sigma | 206,126 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 192,027 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 125,375 | 5,785 | 0 | 0 | For |
| JPMorgan | 130,470 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 121,886 | 0 | 0 | Against |
| Erste Asset Management GmbH | 120,000 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 115,937 | 0 | 0 | 0 | For |
| AQR | 115,774 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 78,367 | 0 | 0 | 0 | For |
| Point72 | 69,137 | 0 | 0 | 0 | For |
| Nuveen | 54,992 | 0 | 0 | 0 | For |
| Goldman Sachs | 53,316 | 0 | 0 | 0 | For |
| Dimensional | 0 | 49,611 | 0 | 0 | Against |
Institutional-manager reports, all 106 managers: 5,371,816 for, 2,831,466 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP as Enanta's independent registered public accounting firm for the 2024 fiscal year.
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“4. To Ratify the Appointment of PricewaterhouseCoopers LLP as Enanta's Independent Registered Public Accounting Firm for the 2024 Fiscal Year”): 14,571,800 for, 27,373 against — passed, per its Form 8-K filed March 12, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2024.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 121,292 | 0 | 0 | 0 | For |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,536 | 0 | 0 | 0 | For |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 13,653 | 0 | 0 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 4,330,668 for, 3,463 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 120,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 120,000 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 21,155,983 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.53% |
| 2 | BlackRock | 4.12% |
| 3 | Fidelity | 2.09% |
| 4 | Charles Schwab | 0.70% |
| 5 | Federated Hermes | 0.57% |
| 6 | Dimensional | 0.42% |
| 7 | Goldman Sachs | 0.42% |
| 8 | Nationwide | 0.38% |
| 9 | JPMorgan | 0.38% |
| 10 | Columbia Threadneedle | 0.32% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | FARALLON CAPITAL MANAGEMENT LLC | 9.78% |
| 2 | BlackRock | 3.82% |
| 3 | DE Shaw | 2.38% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.04% |
| 5 | Renaissance | 1.94% |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 1.82% |
| 7 | Northern Trust | 1.81% |
| 8 | State Street | 1.77% |
| 9 | JACOBS LEVY EQUITY MANAGEMENT, INC | 1.37% |
| 10 | Prudential/PGIM | 1.06% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Armistice Capital, LLC | 2,100,000 | 9.93% | Proxy statement (DEF 14A), proxy filed January 26, 2024 |
| Vanguard Group | 1,938,829 | 9.16% | Form 13F, quarter ended March 31, 2024 |
| Farallon Capital Management, LLC | 1,875,000 | 8.86% | Proxy statement (DEF 14A), proxy filed January 26, 2024 |
| BlackRock | 1,832,980 | 8.66% | Form 13F, quarter ended March 31, 2024 |
| Jay R. Luly, Ph.D. | 1,501,568 | 7.10% | Proxy statement (DEF 14A), proxy filed January 26, 2024 |
| Northern Trust | 933,356 | 4.41% | Form 13F, quarter ended March 31, 2024 |
| Yat Sun Or, Ph.D. | 576,195 | 2.72% | Proxy statement (DEF 14A), proxy filed January 26, 2024 |
| D.E. Shaw | 570,246 | 2.70% | Form 13F, quarter ended March 31, 2024 |
| Renaissance Technologies | 526,100 | 2.49% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 442,072 | 2.09% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 21,155,983 shares outstanding, as reported by ENANTA PHARMACEUTICALS INC. on its Form 10-Q dated January 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ENANTA PHARMACEUTICALS INC.'s shareholder meeting held March 6, 2024, in the 2023-2024 proxy season, 143 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 1,196 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to our named executive officers, as… — ENANTA PHARMACEUTICALS INC.'s filing reports the proposal as approved, with 79% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ENANTA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on March 12, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ENANTA PHARMACEUTICALS INC.’s 10-Q dated January 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ENANTA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “ENANTA PHARMACEUTICALS (ENTA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/enanta-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.